Literature DB >> 23631735

Pathogenesis of H9N2 virus in Chukar partridges.

H Nili1, A Mohammadi, H Habibi, S Firouzi.   

Abstract

Low-pathogenic avian influenza virus (H9N2) is circulating in the poultry industry of many countries in the Middle East and Asia, causing serious economic damage. In this study the clinical signs, antibody response, viral shedding and efficacy of oil emulsion vaccines in Chukar partridges were investigated until 9 days post inoculation (d.p.i.). Seventy-five Chukar partridges (Alectoris chukar) were divided randomly in three groups of challenged (Group C), vaccinated and challenged (Group VC) and control (non-vaccinated and non-challenged [Group NC]), 25 birds/group. Groups C and VC were inoculated with 0.4 ml allantoic fluid containing 10(7) median embryo infective dose/bird of A/Chicken/Iran/772/1998(H9N2) avian influenza virus. Clinical signs, antibody response, viral shedding and vaccine efficacy were evaluated and compared among these groups over 9 days. Clinical signs such as coughing and sneezing with depression and decreased feed and water consumption were observed in Group C. In Group VC only a slight decrease in food and water consumption was observed. Both Groups C and VC showed maximum antibody titre at 9 d.p.i. At 1 d.p.i. the virus was detected from all tissues in challenged group, but the virus was not detected from the spleen and caecal tonsil of Group VC. Group C showed the longest period of viral shedding in the trachea and kidney.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23631735     DOI: 10.1080/03079457.2013.779362

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  6 in total

Review 1.  H9 Influenza Viruses: An Emerging Challenge.

Authors:  Silvia Carnaccini; Daniel R Perez
Journal:  Cold Spring Harb Perspect Med       Date:  2020-06-01       Impact factor: 6.915

2.  Redesign and Validation of a Real-Time RT-PCR to Improve Surveillance for Avian Influenza Viruses of the H9 Subtype.

Authors:  Valentina Panzarin; Sabrina Marciano; Andrea Fortin; Irene Brian; Valeria D'Amico; Federica Gobbo; Francesco Bonfante; Elisa Palumbo; Yoshihiro Sakoda; Kien Trung Le; Duc-Huy Chu; Ismaila Shittu; Clement Meseko; Abdoul Malick Haido; Theophilus Odoom; Mame Nahé Diouf; Fidélia Djegui; Mieke Steensels; Calogero Terregino; Isabella Monne
Journal:  Viruses       Date:  2022-06-10       Impact factor: 5.818

3.  Antiviral activity of the oseltamivir and Melissa officinalis L. essential oil against avian influenza A virus (H9N2).

Authors:  Gholamhosein Pourghanbari; Hasan Nili; Afagh Moattari; Ali Mohammadi; Aida Iraji
Journal:  Virusdisease       Date:  2016-05-21

4.  Prevalence of avian influenza (H9N2) in commercial quail, partridge, and turkey farms in Iran, 2014-2015.

Authors:  Mohammad Hosein Fallah Mehrabadi; Alireza Bahonar; Kamran Mirzaei; Aidin Molouki; Arash Ghalyanchilangeroudi; Seyed Ali Ghafouri; Farshad Tehrani; Swee Hua Erin Lim
Journal:  Trop Anim Health Prod       Date:  2017-10-13       Impact factor: 1.559

Review 5.  A brief summary of the epidemiology and genetic relatedness of avian influenza H9N2 virus in birds and mammals in the Middle East and North Africa.

Authors:  A Nagy; T C Mettenleiter; E M Abdelwhab
Journal:  Epidemiol Infect       Date:  2017-11-23       Impact factor: 4.434

6.  In vitro Acquisition and Retention of Low-Pathogenic Avian Influenza H9N2 by Musca domestica (Diptera: Muscidae).

Authors:  Iman Salamatian; Ali Moshaverinia; Jamshid Razmyar; Mehran Ghaemi
Journal:  J Med Entomol       Date:  2020-02-27       Impact factor: 2.278

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.